Raptiva in Palm and Sole Psoriasis
Clinical trial NCT00972543 · TERMINATED
Trial details
- NCT number
- NCT00972543
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2009-05-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.